|
adiponectin |
64 |
|
obesity |
50 |
|
humans |
33 |
|
male |
30 |
|
type 2 diabetes |
29 |
|
adult |
28 |
|
insulin resistance |
26 |
|
middle aged |
26 |
|
female |
24 |
|
diabetes |
23 |
|
medical sciences |
23 |
|
fatty liver disease |
22 |
|
inflammation |
21 |
|
mice |
21 |
|
aged |
19 |
|
atherosclerosis |
19 |
|
body mass index |
18 |
|
lipocalin-2 |
18 |
|
cohort studies |
17 |
|
enzyme-linked immunosorbent assay |
17 |
|
ischemic stroke |
17 |
|
adipocyte |
16 |
|
animals |
16 |
|
hypertension |
16 |
|
type 2 diabetes mellitus |
16 |
|
chronic hepatitis b |
15 |
|
coronary artery disease |
15 |
|
chinese |
14 |
|
adipokine |
13 |
|
adiponectin - blood |
13 |
|
c-reactive protein |
13 |
|
fatty acid-binding proteins - blood |
13 |
|
gut microbiota |
13 |
|
mice, inbred c57bl |
13 |
|
secondary prevention |
13 |
|
vitamin d |
13 |
|
adipose tissue |
12 |
|
angiogenesis |
12 |
|
cardiovascular diseases |
12 |
|
liver - metabolism |
12 |
|
macrophages |
12 |
|
myocardial infarction |
12 |
|
recurrence |
12 |
|
rna, messenger - metabolism |
12 |
|
cardiovascular disease |
11 |
|
chemicals and cas registry numbers |
11 |
|
cross-sectional studies |
11 |
|
disease progression |
11 |
|
liver fibrosis |
11 |
|
mafld (metabolic associated fatty liver disease) |
11 |
|
metabolism |
11 |
|
overweight |
11 |
|
oxidative stress |
11 |
|
population based study |
11 |
|
signal transduction |
11 |
|
adipocytes - metabolism |
10 |
|
adipokines |
10 |
|
aged, 80 and over |
10 |
|
ampk |
10 |
|
b-type natriuretic peptide |
10 |
|
biological markers - blood |
10 |
|
bradykinin |
10 |
|
cardiac troponin |
10 |
|
exome chip |
10 |
|
fibroblast growth factor |
10 |
|
fibrosis |
10 |
|
insulin |
10 |
|
insulin - metabolism |
10 |
|
liver transplantation |
10 |
|
mendelian randomization |
10 |
|
metabolic syndrome |
10 |
|
prospective studies |
10 |
|
risk factor |
10 |
|
risk prediction |
10 |
|
adiposity - physiology |
9 |
|
antioxidants |
9 |
|
asian continental ancestry group - genetics |
9 |
|
asian-specific |
9 |
|
chemokines |
9 |
|
endothelial dysfunction |
9 |
|
exome-chip association analysis |
9 |
|
genome-wide association studies |
9 |
|
glucose-stimulated insulin secretion |
9 |
|
immunohistochemistry |
9 |
|
molecular weight |
9 |
|
neuroinflammation |
9 |
|
nucleoside analogues |
9 |
|
obstructive sleep apnea |
9 |
|
pax4 |
9 |
|
reverse transcriptase polymerase chain reaction |
9 |
|
risk factors |
9 |
|
3t3-l1 cells |
8 |
|
a-fabp |
8 |
|
adiponectin - biosynthesis - metabolism |
8 |
|
adiponectin - blood - genetics |
8 |
|
adiponectin receptor |
8 |
|
alzheimer's disease |
8 |
|
animal experiment |
8 |
|
aβ |
8 |
|
biology |
8 |
|
biomarker |
8 |
|
blood pressure |
8 |
|
blood pressure - genetics |
8 |
|
breast cancer |
8 |
|
carotid intima-media thickness |
8 |
|
cell line |
8 |
|
cells, cultured |
8 |
|
cognitive impairments |
8 |
|
diabetic retinopathy |
8 |
|
endothelial cells |
8 |
|
endothelial function |
8 |
|
endothelium |
8 |
|
enos |
8 |
|
exercise |
8 |
|
gene |
8 |
|
genetic variants |
8 |
|
gluconeogenesis |
8 |
|
hyperglycemia |
8 |
|
hypertension - blood - genetics |
8 |
|
insr |
8 |
|
insulin resistance - physiology |
8 |
|
jak2/stat3 |
8 |
|
mice, knockout |
8 |
|
myocardial ischemia injury |
8 |
|
nitric oxide |
8 |
|
non-alcoholic fatty liver disease |
8 |
|
obesity - genetics - metabolism |
8 |
|
pi3k/akt |
8 |
|
prediction |
8 |
|
prediction model |
8 |
|
proliferative diabetic retinopathy |
8 |
|
proto-oncogene proteins c-akt - metabolism |
8 |
|
sight-threatening diabetic retinopathy |
8 |
|
signal transduction - drug effects |
8 |
|
single-nucleotide polymorphism |
8 |
|
thiazolidinediones - pharmacology - therapeutic use |
8 |
|
thiazolidinediones - therapeutic use |
8 |
|
a(h1n1)pdm09 |
7 |
|
adipocyte fatty acid binding protein |
7 |
|
adipocyte fatty acid-binding protein |
7 |
|
adipocytes - metabolism - pathology |
7 |
|
adipogenesis |
7 |
|
adiponectin - blood - chemistry - genetics |
7 |
|
adiponectin oligomeric form |
7 |
|
aging |
7 |
|
anti-steatosis |
7 |
|
antiviral agents - therapeutic use |
7 |
|
appl1 |
7 |
|
appl2 |
7 |
|
beiging |
7 |
|
blood glucose - metabolism |
7 |
|
blood–brain barrier |
7 |
|
body composition - physiology |
7 |
|
brain ischemia - blood - diagnosis - mortality |
7 |
|
carcinoma, hepatocellular - blood supply - drug therapy - pathology |
7 |
|
cell membrane - metabolism |
7 |
|
cell survival signaling |
7 |
|
chemokine cxcl10 - metabolism |
7 |
|
china |
7 |
|
depression |
7 |
|
diabetes mellitus |
7 |
|
down-regulation - physiology |
7 |
|
dpp4 inhibitor |
7 |
|
endotoxemia |
7 |
|
fabp4 |
7 |
|
fatty liver - pathology - surgery |
7 |
|
fgf21 |
7 |
|
fib-4 |
7 |
|
fibroblast growth factor 21 |
7 |
|
genetic vectors |
7 |
|
genotype |
7 |
|
graft rejection - blood - drug therapy - pathology |
7 |
|
graft survival - drug effects |
7 |
|
hepatic microcirculation |
7 |
|
hepatitis b, chronic - complications - drug therapy - pathology |
7 |
|
hepatocellular carcinoma |
7 |
|
hepatocytes - metabolism |
7 |
|
immunosuppressive agents - therapeutic use |
7 |
|
influenza |
7 |
|
intra-abdominal fat - physiopathology |
7 |
|
ischaemic stroke |
7 |
|
jnk/c-jun signalling |
7 |
|
lamivudine |
7 |
|
leptin |
7 |
|
lipids |
7 |
|
lipocalin |
7 |
|
liver cirrhosis |
7 |
|
liver cirrhosis - blood - metabolism - pathology - virology |
7 |
|
liver neoplasms, experimental - blood supply - drug therapy - pathology |
7 |
|
magnetic resonance imaging |
7 |
|
marginal graft |
7 |
|
matrix metalloproteinase 9 - metabolism |
7 |
|
mmp-9 |
7 |
|
neovascularization, pathologic - drug therapy |
7 |
|
nfs |
7 |
|
obesity - blood - complications |
7 |
|
obesity - genetics |
7 |
|
pegylated interferon alfa-2a |
7 |
|
personalized medicine |
7 |
|
pharmacy and pharmacology environmental studies |
7 |
|
polymorphism, genetic |
7 |
|
ppar gamma - agonists - metabolism |
7 |
|
rats |
7 |
|
reactive oxygen species - metabolism |
7 |
|
severe |
7 |
|
severity of illness index |
7 |
|
sglt2 inhibitor |
7 |
|
sirt1 |
7 |
|
sleep apnea, obstructive - diagnosis - physiopathology |
7 |
|
stroke - blood - diagnosis - mortality |
7 |
|
subcutaneous fat, abdominal - physiopathology |
7 |
|
sustained virological response |
7 |
|
sympathetic activity |
7 |
|
sympathetic nervous system - physiopathology |
7 |
|
toxicology and environmental safety |
7 |
|
triglycerides - blood |
7 |
|
type 1 diabetes |
7 |
|
adaptor protein |
6 |
|
adaptor proteins, signal transducing - genetics - metabolism |
6 |
|
adiponectin - genetics |
6 |
|
adiponectin - metabolism |
6 |
|
adipose tissue - chemistry |
6 |
|
advanced glycation end-products |
6 |
|
angiopoietin-like 4 |
6 |
|
biogenesis |
6 |
|
biological markers - analysis |
6 |
|
blood glucose - analysis |
6 |
|
blood pressure - physiology |
6 |
|
blood-brain barrier |
6 |
|
bms309403 |
6 |
|
c-reactive protein - analysis |
6 |
|
cancer |
6 |
|
cardiomyopathy |
6 |
|
case-control studies |
6 |
|
cell density |
6 |
|
china - epidemiology |
6 |
|
diabetes mellitus, type 2 - blood - drug therapy |
6 |
|
diabetes mellitus, type 2 - diagnosis - ethnology - genetics |
6 |
|
diagnosis |
6 |
|
disease models, animal |
6 |
|
double-blind method |
6 |
|
endocrinology |
6 |
|
energy metabolism |
6 |
|
ep4 |
6 |
|
escherichia coli - genetics |
6 |
|
follow-up studies |
6 |
|
genetic predisposition to disease |
6 |
|
genetic predisposition to disease - genetics |
6 |
|
genetic variation |
6 |
|
glucose intolerance - blood - genetics |
6 |
|
glyburide - therapeutic use |
6 |
|
glycosylation |
6 |
|
heart |
6 |
|
high-fat diet |
6 |
|
hippocampal neurogenesis |
6 |
|
homeostasis |
6 |
|
hong kong - epidemiology |
6 |
|
hyperglycaemia |
6 |
|
hypertension - blood - epidemiology |
6 |
|
hypertension - epidemiology |
6 |
|
hypertriglyceridemia |
6 |
|
hypertriglyceridemia - epidemiology |
6 |
|
hypoglycemic agents - therapeutic use |
6 |
|
igt |
6 |
|
impaired glucose tolerance |
6 |
|
insulin resistance - genetics |
6 |
|
intra-abdominal fat |
6 |
|
ischemia-reperfusion injury |
6 |
|
jnk mitogen-activated protein kinases - genetics - metabolism |
6 |
|
likelihood functions |
6 |
|
linkage disequilibrium |
6 |
|
lipocalins |
6 |
|
lipopolysaccharides |
6 |
|
lipotoxicity |
6 |
|
macrophage |
6 |
|
metabolic syndrome x - blood - epidemiology - etiology |
6 |
|
metabolic syndrome x - genetics |
6 |
|
metastasis |
6 |
|
mice, obese |
6 |
|
models, biological |
6 |
|
molecular sequence data |
6 |
|
obesity - blood |
6 |
|
obesity - epidemiology |
6 |
|
odds ratio |
6 |
|
ph domain and leucine zipper containing 1 (appl1) |
6 |
|
phosphotyrosine interaction |
6 |
|
physical exercise |
6 |
|
polymorphism, single nucleotide - genetics |
6 |
|
potassium channels, inwardly rectifying - genetics |
6 |
|
pparγ |
6 |
|
prediabetic state - diagnosis - ethnology - genetics |
6 |
|
predictive value of tests |
6 |
|
proteins - metabolism |
6 |
|
proteomics |
6 |
|
rage |
6 |
|
receptors, immunologic - blood - drug effects |
6 |
|
recombinant proteins - metabolism |
6 |
|
regression analysis |
6 |
|
rna interference |
6 |
|
sensitivity and specificity |
6 |
|
sleep apnea, obstructive - metabolism |
6 |
|
small-for-size fatty liver |
6 |
|
soluble receptor for advanced glycation end-products |
6 |
|
therapeutic |
6 |
|
thiazolidinedione |
6 |
|
tnf receptor-associated factor 6 - genetics - metabolism |
6 |
|
treatment outcome |
6 |
|
ubiquitination |
6 |
|
vascular homeostasis |
6 |
|
visceral fat |
6 |
|
waist circumference |
6 |
|
acetylcysteine - pharmacology - therapeutic use |
5 |
|
acyl coenzyme a - metabolism |
5 |
|
adaptive thermogenesis |
5 |
|
adaptor proteins, signal transducing - antagonists and inhibitors - genetics - physiology |
5 |
|
adaptor proteins, signal transducing - metabolism |
5 |
|
adenoviridae - genetics |
5 |
|
adipocyte fatty-acid-binding protein |
5 |
|
adiponectin - blood - genetics - metabolism |
5 |
|
adiponectin - deficiency - therapeutic use |
5 |
|
adiponectin and adipokine |
5 |
|
adipose tissue - drug effects - metabolism |
5 |
|
adipose tissue - metabolism |
5 |
|
adult neurogenesis |
5 |
|
affinity chromatography |
5 |
|
aging - metabolism |
5 |
|
allopurinol - pharmacology - therapeutic use |
5 |
|
amino acid sequence |
5 |
|
anoxia - metabolism |
5 |
|
antineoplastic activity |
5 |
|
antineoplastic agents - pharmacology |
5 |
|
antioxidants - pharmacology - therapeutic use |
5 |
|
aorta, thoracic - drug effects - metabolism - physiopathology |
5 |
|
apoptosis - drug effects |
5 |
|
autoimmune hypoglycaemia |
5 |
|
baduanjin qigong exercise |
5 |
|
base sequence |
5 |
|
bcd-ipsc disease model |
5 |
|
bile acids |
5 |
|
binding, competitive |
5 |
|
bioaccumulation |
5 |
|
blood glucose - drug effects |
5 |
|
blood sampling |
5 |
|
cardiac dysfunction |
5 |
|
cardio-renal metabolic syndrome |
5 |
|
carotid artery diseases - diagnosis |
5 |
|
carrier proteins - metabolism |
5 |
|
cell aging - drug effects - physiology |
5 |
|
cell cycle proteins - metabolism |
5 |
|
cell line, tumor |
5 |
|
cell movement - drug effects |
5 |
|
cell proliferation - drug effects |
5 |
|
cholesterol - blood |
5 |
|
cholesterol homeostasis |
5 |
|
chronic fatigue syndrome (cfs) |
5 |
|
chronic periodontitis |
5 |
|
coronary heart disease |
5 |
|
cyp2c9 |
5 |
|
cyp4v2 gene mutant psc control |
5 |
|
cyp7a1 |
5 |
|
depression-like behavior |
5 |
|
diabetes complications - drug therapy - metabolism - pathology - physiopathology |
5 |
|
diabetes mellitus, type 2 - blood - drug therapy - metabolism |
5 |
|
diabetes mellitus, type 2 - enzymology |
5 |
|
diabetic cardiomyopathy |
5 |
|
diacylglycerol |
5 |
|
dietary fats - administration & dosage |
5 |
|
differentiation |
5 |
|
disease association |
5 |
|
dose-response relationship, drug |
5 |
|
dyslipidemia |
5 |
|
elisa |
5 |
|
endothelial cells - drug effects - metabolism - physiology |
5 |
|
endothelial nitric oxide synthase/nitric oxide (enos/no) pathway |
5 |
|
endothelin-1 - metabolism |
5 |
|
endothelium, vascular - drug effects - metabolism - physiopathology |
5 |
|
endothelium, vascular - drug effects - physiopathology |
5 |
|
endothelium, vascular - metabolism |
5 |
|
escherichia coli |
5 |
|
exercise responsiveness |
5 |
|
expression and purification |
5 |
|
family history |
5 |
|
fatty acid-binding proteins - physiology |
5 |
|
fatty-acid-binding proteins |
5 |
|
fibrinolytic agents - pharmacology - therapeutic use |
5 |
|
fusion protein |
5 |
|
gastroenterology medical sciences |
5 |
|
gene expression regulation |
5 |
|
gene frequency |
5 |
|
gene knockdown techniques |
5 |
|
glucocorticoid receptor |
5 |
|
glucose - biosynthesis - metabolism |
5 |
|
glucose dysregulation |
5 |
|
glycaemia |
5 |
|
gold compounds - pharmacology |
5 |
|
heart failure |
5 |
|
hepatocytes - enzymology |
5 |
|
humdisease |
5 |
|
hypercholesterolemia |
5 |
|
hyperglycemia - diagnosis |
5 |
|
hyperglycemia - genetics |
5 |
|
hypoglycemic agents - pharmacology - therapeutic use |
5 |
|
hypothalamus |
5 |
|
hypoxia |
5 |
|
inflammation - immunology - metabolism |
5 |
|
insulin - pharmacology |
5 |
|
insulin receptor autoantibodies |
5 |
|
interaction profiling |
5 |
|
ionization time of flight mass spectrometry |
5 |
|
ischaemic heart disease |
5 |
|
lipidomic study |
5 |
|
lipocalins - genetics - physiology |
5 |
|
liquid chromatography-tan-dem mass spectrometry |
5 |
|
liver - drug effects - injuries - metabolism |
5 |
|
liver glycogen - metabolism |
5 |
|
liver graft injury |
5 |
|
liver injury |
5 |
|
longitudinal studies |
5 |
|
lycium barbarum polysaccharides |
5 |
|
lyso-phosphatidylcholine |
5 |
|
macrophages - metabolism |
5 |
|
mammary neoplasms, experimental - drug therapy |
5 |
|
matrix-assisted laser desorption |
5 |
|
metabolic syndrome x - blood |
5 |
|
metabolic syndrome x - metabolism |
5 |
|
metalloporphyrins - pharmacology |
5 |
|
mice, nude |
5 |
|
microvascular complications |
5 |
|
mitochondria |
5 |
|
mitochondrial proteins - genetics - metabolism |
5 |
|
muscle, skeletal - metabolism |
5 |
|
mutagenesis, site-directed |
5 |
|
myocardial ischaemia/reperfusion |
5 |
|
nephropathy |
5 |
|
nerve tissue proteins - metabolism |
5 |
|
nitric oxide - biosynthesis |
5 |
|
nitric oxide - metabolism |
5 |
|
non-alcoholic steatohepatitis |
5 |
|
obesity - blood - diagnosis |
5 |
|
obesity - blood - metabolism |
5 |
|
obesity - metabolism - physiopathology |
5 |
|
obesity - physiopathology |
5 |
|
oncogene proteins - blood |
5 |
|
oncogene proteins - deficiency - genetics - physiology |
5 |
|
phosphorylation |
5 |
|
phosphorylation - drug effects |
5 |
|
plasminogen activator inhibitor 1 - biosynthesis |
5 |
|
plasminogen activator inhibitor 1 - blood - genetics - metabolism |
5 |
|
poly-unsaturated fatty acid |
5 |
|
polyamination |
5 |
|
polymorphism, single nucleotide |
5 |
|
porphyrin derivative |
5 |
|
primary prevention |
5 |
|
protein binding |
5 |
|
protein interaction mapping - methods |
5 |
|
protein structure, tertiary |
5 |
|
proto-oncogene proteins - blood |
5 |
|
reactive oxygen species |
5 |
|
recombinant proteins - genetics - metabolism |
5 |
|
regulatory t cells |
5 |
|
resistin - genetics |
5 |
|
rosiglitazone |
5 |
|
rpe |
5 |
|
serpin e2 |
5 |
|
serpins - blood - metabolism |
5 |
|
signaling |
5 |
|
sirtuin 1 |
5 |
|
sirtuin 3 |
5 |
|
sirtuins - genetics - metabolism |
5 |
|
stem cells - drug effects - metabolism - physiology |
5 |
|
sulfonylurea compounds - pharmacology - therapeutic use |
5 |
|
surgery |
5 |
|
thiazolidinediones - toxicity |
5 |
|
thrombotic dieases |
5 |
|
toll-like receptor 4 |
5 |
|
transcription factor ap-1 - genetics - metabolism |
5 |
|
transcription factor yy1 |
5 |
|
transduction, genetic |
5 |
|
triacylglycerol |
5 |
|
tumor recurrence |
5 |
|
type b insulin resistance |
5 |
|
uncoupling protein 2 |
5 |
|
28 inflammation in type 2 diabetes |
4 |
|
3t3 cells |
4 |
|
active transport, cell nucleus - drug effects |
4 |
|
adaptor proteins, signal transducing |
4 |
|
adipocyte precursor cells |
4 |
|
adipokines - blood |
4 |
|
adipokines - metabolism - pharmacology |
4 |
|
adiponectin - chemistry |
4 |
|
adiponectin - deficiency - hysiology - therapeutic use |
4 |
|
adiponectin - genetics - pharmacology |
4 |
|
adiponectin - pharmacology |
4 |
|
adipopharmacology |
4 |
|
adipose remodeling |
4 |
|
adipose tissue, brown - metabolism |
4 |
|
alzheimer’s disease |
4 |
|
amlodipine |
4 |
|
amlodipine - pharmacology - therapeutic use |
4 |
|
amp-activated protein kinases |
4 |
|
amp-activated protein kinases - metabolism |
4 |
|
angiopoietin-like proteins |
4 |
|
angiopoietins |
4 |
|
angiotensin ii |
4 |
|
anthracyclines |
4 |
|
anthropometry - methods |
4 |
|
antibody drug candidate |
4 |
|
anticholesteremic agents - pharmacology - therapeutic use |
4 |
|
antihypertensive agent |
4 |
|
antihypertensive agents - pharmacology - therapeutic use |
4 |
|
antioxidants - therapeutic use |
4 |
|
aorta - metabolism |
4 |
|
apocynin |
4 |
|
apolipoprotein |
4 |
|
apoptosis |
4 |
|
apoptosis - drug effects - physiology |
4 |
|
asian continental ancestry group |
4 |
|
atorvastatin |
4 |
|
autoimmunity |
4 |
|
autophagy |
4 |
|
bdnf |
4 |
|
beta catenin - metabolism |
4 |
|
biological markers |
4 |
|
blood pressure - drug effects |
4 |
|
blood proteins - physiology |
4 |
|
blood vessels - drug effects - metabolism |
4 |
|
blotting, northern |
4 |
|
brachial artery - physiology - ultrasonography |
4 |
|
brain-derived neurotrophic factor |
4 |
|
breast carcinogenesis |
4 |
|
breast neoplasms - metabolism - pathology - therapy |
4 |
|
cardiovascular diseases - blood - epidemiology - etiology |
4 |
|
cardiovascular diseases - metabolism - prevention and control |
4 |
|
carotid artery |
4 |
|
carrier proteins - blood |
4 |
|
carrier proteins - genetics |
4 |
|
cattle |
4 |
|
cd8 |
4 |
|
cell adhesion |
4 |
|
cell biology |
4 |
|
cell cycle - drug effects |
4 |
|
cell differentiation |
4 |
|
cell hypoxia |
4 |
|
cell nucleus - drug effects - metabolism |
4 |
|
cholesterol |
4 |
|
chromatography, high pressure liquid |
4 |
|
cloning, molecular |
4 |
|
cluster of differentiation |
4 |
|
coronary artery disease - blood - complications - drug therapy |
4 |
|
corticosterone |
4 |
|
cox-1 |
4 |
|
creb-h |
4 |
|
culture media - chemistry - pharmacology |
4 |
|
cyclin d1 - metabolism |
4 |
|
diabetes mellitus, experimental - complications - enzymology - physiopathology |
4 |
|
diabetes mellitus, experimental - drug therapy - metabolism |
4 |
|
diabetes mellitus, type 2 - blood - pathology |
4 |
|
diabetic complication |
4 |
|
dietary fats - administration & dosage - pharmacology |
4 |
|
drug combinations |
4 |
|
drug therapy, combination |
4 |
|
electrophoresis, gel, two-dimensional |
4 |
|
endothelial progenitor cells |
4 |
|
endothelium, vascular - cytology - metabolism |
4 |
|
endothelium, vascular - drug effects - enzymology - physiology |
4 |
|
endothelium, vascular - drug effects - metabolism - physiology |
4 |
|
endothelium, vascular - drug effects - pathology |
4 |
|
endothelium, vascular - drug effects - physiology |
4 |
|
endothelium-derivedcontractingfactor(s) |
4 |
|
energy metabolism - drug effects |
4 |
|
enzyme activation - drug effects |
4 |
|
eosinophils |
4 |
|
eotaxin |
4 |
|
ets-domain protein elk-1 - biosynthesis |
4 |
|
exosome |
4 |
|
extracellular signal-regulated map kinases - antagonists & inhibitors - metabolism |
4 |
|
fat |
4 |
|
fatty liver |
4 |
|
feeding behavior - drug effects |
4 |
|
fetal blood |
4 |
|
fibroblast growth factor 2 - pharmacology |
4 |
|
fibroblast growth factors - metabolism |
4 |
|
fibroblasts |
4 |
|
gene delivery |
4 |
|
gene expression |
4 |
|
gene therapy - methods |
4 |
|
gi proteins |
4 |
|
glucose - metabolism |
4 |
|
glucose intolerance - complications - physiopathology |
4 |
|
glucose intolerance - genetics - metabolism |
4 |
|
glucose tolerance test |
4 |
|
glucose transport proteins, facilitative - biosynthesis |
4 |
|
glucose transporter type 2 |
4 |
|
glycogen synthase kinase 3 - antagonists & inhibitors - metabolism |
4 |
|
glycoproteins - blood |
4 |
|
graft rejection - immunology - prevention and control |
4 |
|
heart transplantation - immunology |
4 |
|
hepatic stellate cells |
4 |
|
heptanoic acids - pharmacology - therapeutic use |
4 |
|
heterozygote |
4 |
|
high-fat-diet-induced obesity |
4 |
|
hippocampal cell proliferation |
4 |
|
histamine |
4 |
|
hypertension - blood - complications - drug therapy |
4 |
|
hypoxia-inducible factor 1, alpha subunit - genetics - metabolism |
4 |
|
hypoxia-inducible factor 1α subunit |
4 |
|
igf-1 |
4 |
|
il-5 |
4 |
|
immunosuppressive agents - pharmacology - therapeutic use |
4 |
|
induced pluripotent stem cells |
4 |
|
innate immunity |
4 |
|
insulin - blood |
4 |
|
insulin sensitivity |
4 |
|
intercellular signaling peptides and proteins |
4 |
|
interleukin-5 - antagonists and inhibitors |
4 |
|
isometric contraction - drug effects - physiology |
4 |
|
jnk |
4 |
|
keratinocytes |
4 |
|
kupffer cells |
4 |
|
ldlr |
4 |
|
lipid metabolism - drug effects |
4 |
|
lipoprotein lipase |
4 |
|
liver - drug effects - metabolism - physiopathology |
4 |
|
liver sinusoidal endothelial cells |
4 |
|
lymphocyte antigen 96 |
4 |
|
lysine - chemistry |
4 |
|
map kinase |
4 |
|
map kinase kinase kinases - antagonists & inhibitors - metabolism |
4 |
|
mesenchymal stem cells |
4 |
|
metabolic syndrome x - blood - etiology |
4 |
|
mitochondria - drug effects - metabolism |
4 |
|
mitochondrion |
4 |
|
motor activity - drug effects |
4 |
|
mouse models |
4 |
|
multienzyme complexes - genetics - metabolism |
4 |
|
multiple lowdose streptozotocin-induced diabetes |
4 |
|
muscle, skeletal - drug effects - enzymology - physiopathology |
4 |
|
neovascularization |
4 |
|
neovascularization, physiologic - physiology |
4 |
|
nephrology |
4 |
|
neutralizing monoclonal antibody 6h2 |
4 |
|
nf-κb pathway |
4 |
|
nfκb |
4 |
|
nitric oxide synthase type iii - drug effects - metabolism |
4 |
|
nlrp3 |
4 |
|
oral antidiabetic agent |
4 |
|
oxygen - metabolism |
4 |
|
pigment epithelium derived factor |
4 |
|
placenta |
4 |
|
polysomnography - methods |
4 |
|
ppar-γ |
4 |
|
prediabetes |
4 |
|
prevalence |
4 |
|
prostanoids |
4 |
|
protein 14-3-3 |
4 |
|
protein kinase b |
4 |
|
protein processing, post-translational |
4 |
|
protein-serine-threonine kinases - genetics - metabolism |
4 |
|
pyrroles - pharmacology - therapeutic use |
4 |
|
raf kinases - antagonists & inhibitors - metabolism |
4 |
|
receptors, adiponectin |
4 |
|
receptors, adiponectin - metabolism |
4 |
|
receptors, cell surface - genetics |
4 |
|
recombinant fusion proteins - metabolism |
4 |
|
recombinant proteins - administration & dosage - pharmacology |
4 |
|
serum response factor - metabolism |
4 |
|
sleep apnea, obstructive - blood - diagnosis |
4 |
|
sodium glucose co-transporter 2 inhibitors |
4 |
|
steatosis |
4 |
|
stem cells - metabolism |
4 |
|
stress |
4 |
|
sympathetic nervous system |
4 |
|
tgfβ1 |
4 |
|
thiazolidinediones - pharmacology |
4 |
|
time factors |
4 |
|
tp receptors |
4 |
|
type 1diabetes |
4 |
|
type 2 immunity |
4 |
|
umbilical veins |
4 |
|
up-regulation - drug effects |
4 |
|
vascular diseases - physiopathology - prevention & control |
4 |
|
vascular endothelial growth factor a |
4 |
|
vascular endothelial growth factor a - pharmacology |
4 |
|
vasculature |
4 |
|
vasculopathy |
4 |
|
vasodilation |
4 |
|
vasodilation - drug effects - physiology |
4 |
|
wnt/β-catenin signaling |
4 |
|
xenograft model antitumor assays - methods |
4 |
|
a-fabp inhibitor |
3 |
|
acetylcholine |
3 |
|
acromegaly - blood |
3 |
|
active transport, cell nucleus |
3 |
|
adipocytes - drug effects |
3 |
|
adipocytes - drug effects - physiology |
3 |
|
adipocytes - physiology |
3 |
|
adiponectin - chemistry - genetics - metabolism - secretion |
3 |
|
adiponectin - pharmacology - physiology |
3 |
|
adiponectin - physiology |
3 |
|
adiporon |
3 |
|
ageing |
3 |
|
akt |
3 |
|
alcohol drinking - metabolism |
3 |
|
alcoholic liver disease |
3 |
|
alpha 2 macroglobulin |
3 |
|
alpha-macroglobulins - physiology |
3 |
|
amino acid motifs - physiology |
3 |
|
amino acid substitution |
3 |
|
aneurysms |
3 |
|
ang ii type 1 receptors |
3 |
|
angiopoietins - genetics - metabolism |
3 |
|
animal cell |
3 |
|
anti-inflammation |
3 |
|
anti-inflammatory agents - chemical synthesis - chemistry - pharmacology |
3 |
|
anti-inflammatory agents - pharmacology - therapeutic use |
3 |
|
anti-oxidant |
3 |
|
antioxidants - chemistry - pharmacology |
3 |
|
aorta |
3 |
|
aorta - cytology - metabolism |
3 |
|
aromatic substituted pyrazoles |
3 |
|
astragalus extract |
3 |
|
atherosclerosis - enzymology - pathology |
3 |
|
autoimmune diabetes |
3 |
|
bacteroides stercoris |
3 |
|
bcaas |
3 |
|
behavior |
3 |
|
bending stability |
3 |
|
berberine - pharmacology - therapeutic use |
3 |
|
biological monitoring |
3 |
|
biomedical applications |
3 |
|
blood proteins - chemistry - metabolism |
3 |
|
blood vessel remodeling |
3 |
|
blotting, western |
3 |
|
bone marrow |
3 |
|
bone morphogenetic protein 4 - antagonists & inhibitors - metabolism |
3 |
|
bone morphogenetic protein receptors, type i - metabolism |
3 |
|
bone morphogenic protein 4 |
3 |
|
brachial artery - physiopathology |
3 |
|
breast neoplasms - etiology - metabolism - pathology |
3 |
|
c-jun n-terminal kinase (jnk) |
3 |
|
c-reactive protein (crp) sensors |
3 |
|
calcium |
3 |
|
calorie restriction |
3 |
|
calycosin |
3 |
|
cardiac-specific c-kit+ cells |
3 |
|
cardiovascular diseases - drug therapy - physiopathology |
3 |
|
cardiovascular diseases - epidemiology |
3 |
|
cardiovascular diseases - etiology |
3 |
|
carnitine o-palmitoyltransferase - antagonists and inhibitors - genetics - metabolism |
3 |
|
carnitine palmitoyltransferase 1a (cpt1a) |
3 |
|
carrier proteins - metabolism - pharmacology |
3 |
|
cell aging - physiology |
3 |
|
cell fractionation |
3 |
|
cell isolation |
3 |
|
cell nucleus - metabolism |
3 |
|
cell proliferation |
3 |
|
chromatography, affinity |
3 |
|
chromatography, liquid |
3 |
|
circadian rhythm |
3 |
|
cognitive impairment |
3 |
|
contraction |
3 |
|
cpg islands |
3 |
|
creb |
3 |
|
culture media - chemistry |
3 |
|
cxcl10 |
3 |
|
cxcr3 |
3 |
|
cyclic amp - metabolism |
3 |
|
cyclin-dependent kinase 5 |
3 |
|
cyclin-dependent kinase 5 - antagonists and inhibitors - physiology |
3 |
|
cycloheximide |
3 |
|
cyclooxygenase |
3 |
|
cyclooxygenase 2 - genetics - metabolism |
3 |
|
cyclooxygenase 2 - metabolism |
3 |
|
cyclooxygenase-2 |
3 |
|
dendritic cell |
3 |
|
diabetes mellitus, type 2 - blood - physiopathology - ultrasonography |
3 |
|
diabetes mellitus, type 2 - epidemiology |
3 |
|
diet, high-fat |
3 |
|
dimerization |
3 |
|
dna methylation |
3 |
|
dna primers |
3 |
|
drug design |
3 |
|
dyslipidemias - blood |
3 |
|
egcg |
3 |
|
eicosanoids |
3 |
|
electrophoresis, polyacrylamide gel |
3 |
|
endothelial cells - drug effects - enzymology |
3 |
|
endothelial nitric oxide synthase |
3 |
|
endothelial senescence |
3 |
|
endothelin-1 |
3 |
|
endothelium, vascular - cytology - physiopathology - ultrasonography |
3 |
|
endothelium, vascular - enzymology - metabolism - pathology |
3 |
|
endothelium-dependent contractions |
3 |
|
endothelium-derived contracting factor |
3 |
|
endothelium-derived contracting factors |
3 |
|
endotoxin shock |
3 |
|
enzyme inhibitors - metabolism |
3 |
|
ep4 receptor |
3 |
|
epigenesis, genetic |
3 |
|
escherichia coli - metabolism |
3 |
|
estrogen receptor beta |
3 |
|
et-1 |
3 |
|
ethanol |
3 |
|
extracellular fluid - metabolism |
3 |
|
extracellular matrix proteins - genetics |
3 |
|
fatty acid |
3 |
|
fatty acid binding protein 4 |
3 |
|
fatty acid-binding proteins - antagonists and inhibitors |
3 |
|
fatty acids - blood |
3 |
|
fatty acids - metabolism |
3 |
|
fatty acids - toxicity |
3 |
|
fatty acids, nonesterified - metabolism |
3 |
|
fatty liver - drug therapy |
3 |
|
fatty liver - etiology - physiopathology - therapy |
3 |
|
fgfr1 |
3 |
|
fibroblast growth factor-21 |
3 |
|
fibroblast growth factors - biosynthesis |
3 |
|
fibroblast growth factors - blood |
3 |
|
gene expression - drug effects |
3 |
|
gene expression regulation - physiology |
3 |
|
gene expression regulation, neoplastic |
3 |
|
genome wide association analysis |
3 |
|
gerotarget |
3 |
|
glycemic control |
3 |
|
glycogen synthase kinase 3 - physiology |
3 |
|
growth hormone |
3 |
|
growth hormone - metabolism |
3 |
|
hdl-cholesterol |
3 |
|
hepatic steatosis |
3 |
|
high fat diet |
3 |
|
hippocampal plasticity |
3 |
|
hippocampus |
3 |
|
hmgb1 |
3 |
|
hormone |
3 |
|
hormones |
3 |
|
host-microbial interactions |
3 |
|
human c1q and tumor necrosis factor related protein 2 (hctrp2) |
3 |
|
human growth hormone - metabolism |
3 |
|
human growth hormone - secretion |
3 |
|
human platelet-derived growth factor a |
3 |
|
hyperglycemia - drug therapy - metabolism |
3 |
|
hypertension, renal - metabolism |
3 |
|
immunoglobulin enhancer binding protein |
3 |
|
immunomodulation |
3 |
|
inflammation - drug therapy - physiopathology |
3 |
|
inflammation related diseases |
3 |
|
inflammatory cytokines |
3 |
|
inflammatory response |
3 |
|
infrapatellar fat pad |
3 |
|
intercellular signaling peptides and proteins - blood |
3 |
|
intercellular signaling peptides and proteins - blood - chemistry - isolation & purification |
3 |
|
intercellular signaling peptides and proteins - genetics |
3 |
|
intrahepatic triglyceride content |
3 |
|
isoelectric focusing |
3 |
|
isoproterenol |
3 |
|
issue 148 |
3 |
|
klb |
3 |
|
kupffer cell |
3 |
|
labyrinthine zone |
3 |
|
learning and memory |
3 |
|
lipid metabolism |
3 |
|
lipoprotein lipase - antagonists & inhibitors - genetics - metabolism |
3 |
|
lipoproteins, hdl - blood |
3 |
|
lkb1 |
3 |
|
machine learning |
3 |
|
machine learning algorithm |
3 |
|
macrophage infiltration and polarization |
3 |
|
magnetic resonance spectroscopy |
3 |
|
mammary neoplasms, animal - metabolism - pathology |
3 |
|
map kinase signaling system - physiology |
3 |
|
mass spectrometry |
3 |
|
mass spectrometry - methods |
3 |
|
mcd diet |
3 |
|
mesenchymal stem cells - chemistry - physiology |
3 |
|
metabolic inflammation |
3 |
|
metabolic outcomes |
3 |
|
metabolic regulation |
3 |
|
metabolic syndrome x - blood - diagnosis |
3 |
|
metabolic syndrome x - complications - prevention & control |
3 |
|
methionine - metabolism |
3 |
|
microbiota transplantation |
3 |
|
microbiota-directed foods |
3 |
|
mir-3059-5p |
3 |
|
mtor |
3 |
|
mutation |
3 |
|
mutation, missense |
3 |
|
nash |
3 |
|
neoplasms, hormone-dependent - metabolism |
3 |
|
neutrophil elastase |
3 |
|
nf-κb |
3 |
|
nitric oxide bioavailability |
3 |
|
nitric oxide synthase type iii - metabolism |
3 |
|
nlrp3 inflammasome |
3 |
|
notoginsenoside ft1 |
3 |
|
obesity - complications |
3 |
|
obesity - complications - metabolism |
3 |
|
obesity, morbid - blood |
3 |
|
organic transistors |
3 |
|
osteoarthritis |
3 |
|
oxidation-reduction |
3 |
|
oxidative stress - physiology |
3 |
|
p25 |
3 |
|
p38 mitogen-activated protein kinases - metabolism |
3 |
|
panax notoginseng |
3 |
|
pedigree |
3 |
|
peptide mapping - methods |
3 |
|
periodontal disease |
3 |
|
periodontal diseases |
3 |
|
periodontics |
3 |
|
periodontium-gingiva |
3 |
|
pi3k |
3 |
|
pichia - genetics |
3 |
|
pichia pastoris |
3 |
|
polymerase chain reaction |
3 |
|
polymorphism, restriction fragment length |
3 |
|
polyphenols |
3 |
|
ppar gamma - physiology |
3 |
|
pressure overload |
3 |
|
pro-inflammatory adipokine |
3 |
|
pro-inflammatory cytokines |
3 |
|
programmed death-1 ligand |
3 |
|
proinflammatory cytokines |
3 |
|
promoter regions, genetic |
3 |
|
prostacyclin |
3 |
|
prostaglandin e receptor |
3 |
|
prostaglandin e2 |
3 |
|
protease inhibitors |
3 |
|
protein isoforms |
3 |
|
protein processing, post-translational - drug effects |
3 |
|
protein purification |
3 |
|
protein structure, tertiary - physiology |
3 |
|
proteins - genetics - isolation & purification - metabolism |
3 |
|
proteins - metabolism - pharmacology |
3 |
|
proteome |
3 |
|
proteome - analysis |
3 |
|
proteomics - methods |
3 |
|
pyrazoles - chemical synthesis - chemistry - pharmacology |
3 |
|
randomized controlled trials as topic |
3 |
|
rats, inbred shr |
3 |
|
rats, inbred wky |
3 |
|
receptor, melanocortin, type 4 - genetics - metabolism |
3 |
|
receptors, cell surface - metabolism |
3 |
|
receptors, estrogen - metabolism |
3 |
|
receptors, prostaglandin e, ep4 subtype - agonists - metabolism |
3 |
|
recombinant fusion proteins - genetics - isolation & purification - metabolism |
3 |
|
recombinant protein |
3 |
|
recombinant proteins - chemistry |
3 |
|
relaxation |
3 |
|
renal arteries |
3 |
|
renal artery - physiology |
3 |
|
repressor activator protein 1 |
3 |
|
resistant starch |
3 |
|
retinol-binding protein 4 |
3 |
|
rna, small interfering |
3 |
|
sequence alignment - methods |
3 |
|
serotonin |
3 |
|
sirtuin 1 - genetics - metabolism |
3 |
|
smooth muscle cell |
3 |
|
soluble guanylyl cyclase |
3 |
|
sp1 transcription factor - physiology |
3 |
|
stilbenes - chemistry - pharmacology |
3 |
|
streptozotocin |
3 |
|
subchondral bone sclerosis |
3 |
|
systolic arterial blood pressure |
3 |
|
t lymphocytes |
3 |
|
telomeric protein |
3 |
|
the metabolic syndrome |
3 |
|
thrombospondin-1 |
3 |
|
thromboxane prostanoid receptors |
3 |
|
tissue-resident memory t cells |
3 |
|
tlr5 |
3 |
|
tnfsf15 |
3 |
|
toll-like receptor |
3 |
|
toll-like receptor (tlr)-4 |
3 |
|
tp receptor |
3 |
|
transfection - methods |
3 |
|
triglycerides - metabolism |
3 |
|
trypsin - chemistry |
3 |
|
two-dimensional gel electrophoresis |
3 |
|
u46619 |
3 |
|
ultraflexibility |
3 |
|
up-regulation - drug effects - physiology |
3 |
|
vascular injury |
3 |
|
vascular smooth muscle |
3 |
|
vasodilatation |
3 |
|
wine - analysis |
3 |
|
3t3-l1 preadipocyte |
2 |
|
ace2 |
2 |
|
acetaminophen |
2 |
|
acetyl-coa carboxylase - metabolism |
2 |
|
acute liver injury |
2 |
|
acute-phase proteins |
2 |
|
acute-phase proteins - metabolism - pharmacology |
2 |
|
adaptor proteins, signal transducing - physiology |
2 |
|
adenylyl cyclase |
2 |
|
adiponectin - blood - chemistry |
2 |
|
adiponectin - chemistry - metabolism - secretion |
2 |
|
adiponectin - chemistry - pharmacology |
2 |
|
adiponectin - metabolism - pharmacology |
2 |
|
adiponectin - metabolism - physiology |
2 |
|
adipose tissue - cytology - metabolism |
2 |
|
adipose tissue specific knockout |
2 |
|
adolescent |
2 |
|
agonistic antibodies |
2 |
|
akt2 |
2 |
|
alternatively activated macrophages |
2 |
|
amylin |
2 |
|
amyloid - antagonists & inhibitors - pharmacology - physiology |
2 |
|
amyloid - pharmacology |
2 |
|
angiotensin-(1–7) |
2 |
|
antioxidants - metabolism |
2 |
|
apoa1 |
2 |
|
aquaporin 7 |
2 |
|
arterial stiffness |
2 |
|
association |
2 |
|
autoimmunity - physiology |
2 |
|
beta cell apoptosis |
2 |
|
beta cell inflammation |
2 |
|
beta cells |
2 |
|
beta-2-microglobulin |
2 |
|
bexarotene |
2 |
|
biocatalysis |
2 |
|
biological sciences |
2 |
|
biological transport, active - drug effects |
2 |
|
biomarkers |
2 |
|
biopolymers - chemistry |
2 |
|
blood vessels - metabolism |
2 |
|
bodipy |
2 |
|
brown adipocyte |
2 |
|
c2c12 |
2 |
|
calcitonin gene-related peptide |
2 |
|
calcitonin gene-related peptide - pharmacology |
2 |
|
cardiac aging |
2 |
|
cardiac function |
2 |
|
cardiometabolic disease |
2 |
|
cardiometabolic disorders |
2 |
|
cardiomyopathies - etiology - genetics - metabolism - prevention and control |
2 |
|
cardiovascular diseases - etiology - metabolism - prevention and control |
2 |
|
cardiovascular surgery |
2 |
|
case report |
2 |
|
caveolin 1 |
2 |
|
caveolin 3 |
2 |
|
cell nucleus - enzymology |
2 |
|
cell survival |
2 |
|
charge reversal |
2 |
|
chemical fractionation - methods |
2 |
|
child |
2 |
|
cholesterol - biosynthesis - blood |
2 |
|
chromatography, deae-cellulose - methods |
2 |
|
chromatography, gel - methods |
2 |
|
cola beverages |
2 |
|
coronary artery bypass surgery |
2 |
|
coronary disease - metabolism - pathology |
2 |
|
cos cells |
2 |
|
crystallography |
2 |
|
curvature |
2 |
|
cyclic vomiting syndrome |
2 |
|
cystatin c |
2 |
|
dentate gyrus |
2 |
|
dexamethasone - pharmacology |
2 |
|
dextrans |
2 |
|
diabetes mellitus - blood - classification |
2 |
|
diabetes mellitus, type 1 - blood |
2 |
|
diabetes mellitus, type 2 - blood |
2 |
|
diabetes mellitus, type 2 - metabolism |
2 |
|
diabetes mellitus, type 2 - metabolism - pathology |
2 |
|
diabetic complications |
2 |
|
diastolic heart failure |
2 |
|
diet, high-fat - adverse effects |
2 |
|
dietary fats - pharmacology |
2 |
|
digestive system - cytology |
2 |
|
dna, complementary - genetics |
2 |
|
dna, complementary - metabolism |
2 |
|
duodenum |
2 |
|
duodenum - cytology |
2 |
|
eae |
2 |
|
early insulin secretion |
2 |
|
early vascular ageing |
2 |
|
edcf |
2 |
|
electron transport chain |
2 |
|
embryo, nonmammalian |
2 |
|
embryonic stem cells |
2 |
|
embryonic stem cells - cytology |
2 |
|
endocytosis |
2 |
|
endothelin |
2 |
|
endothelium, vascular - metabolism - pathology - physiology |
2 |
|
endothelium-dependent relaxation |
2 |
|
enzyme activation |
2 |
|
enzyme inhibitors - pharmacology |
2 |
|
epinephrine |
2 |
|
epinephrine - pharmacology |
2 |
|
estradiol - blood |
2 |
|
exendin-4 |
2 |
|
exerkines |
2 |
|
exogenous insulin antibody syndrome |
2 |
|
experimental autoimmune encephalomyelitis |
2 |
|
f-actin depolymerization |
2 |
|
fatty acid metabolism |
2 |
|
fatty acid-binding proteins - metabolism |
2 |
|
fatty acids, nonesterified - blood |
2 |
|
fatty liver - blood - complications |
2 |
|
feedback |
2 |
|
ferroptosis |
2 |
|
fibroblast growth factors |
2 |
|
fibroblast growth factors - analysis - blood |
2 |
|
forskolin - pharmacology |
2 |
|
foxo1 |
2 |
|
free radical scavengers - pharmacology |
2 |
|
g protein-coupled receptor 116 (gpr116) |
2 |
|
gastroenterology |
2 |
|
gene expression regulation - genetics |
2 |
|
glucose and fatty acid uptake and metabolism |
2 |
|
glucose homeostasis |
2 |
|
glucose transporter type 4 - metabolism |
2 |
|
glucose uptake |
2 |
|
glutathione transferase - metabolism - physiology |
2 |
|
glycerol efflux |
2 |
|
heart failure with preserved ejection fraction |
2 |
|
heat-shock proteins |
2 |
|
heat-shock proteins - metabolism |
2 |
|
hepatitis - blood - etiology |
2 |
|
heterodimer |
2 |
|
high sucrose |
2 |
|
high-density fermentation |
2 |
|
hindlimb - metabolism |
2 |
|
hiv protease inhibitors - adverse effects - pharmacology |
2 |
|
homeostasis - physiology |
2 |
|
hormone replacement therapy |
2 |
|
hsp20 heat-shock proteins |
2 |
|
human c1q and tumour necrosis factor-related protein-1 |
2 |
|
human umbilical vein endothelial cells - metabolism |
2 |
|
hydrogen-ion concentration |
2 |
|
hyperglycemia - genetics - metabolism |
2 |
|
hyperinsulinism - genetics - metabolism |
2 |
|
hyperlipidemias - chemically induced |
2 |
|
hypoglycaemia |
2 |
|
hypoglycemic agents - pharmacology |
2 |
|
il-13 |
2 |
|
il-4 |
2 |
|
immunoprecipitation |
2 |
|
immunotherapy |
2 |
|
induced pluripotent stem cell |
2 |
|
insulin - secretion |
2 |
|
insulin antagonists - pharmacology |
2 |
|
insulin granule biogenesis |
2 |
|
insulin secretion |
2 |
|
insulin signal pathway |
2 |
|
insulin-like growth factor |
2 |
|
insulin-like growth factor i - pharmacology |
2 |
|
insulin-secreting cells - immunology |
2 |
|
insulin-secreting cells - secretion - ultrastructure |
2 |
|
interleukin-6 |
2 |
|
interleukin-6 - biosynthesis - chemistry - immunology - isolation & purification |
2 |
|
ion channels - deficiency - genetics - metabolism |
2 |
|
islet amyloid polypeptide |
2 |
|
isoelectric point |
2 |
|
isoenzymes - antagonists & inhibitors - genetics - metabolism |
2 |
|
isomerism |
2 |
|
jnk mitogen-activated protein kinases - metabolism |
2 |
|
kcnq1 |
2 |
|
kidney injury |
2 |
|
killer cells, natural - metabolism |
2 |
|
left anterior descending coronary artery ligation |
2 |
|
left ventricular hypertrophy |
2 |
|
linear models |
2 |
|
lipid |
2 |
|
lipid regulation |
2 |
|
lipocalin 14 |
2 |
|
lipocalins - blood |
2 |
|
lipocalins - metabolism - pharmacology |
2 |
|
lipocalin‐2 |
2 |
|
lipodystrophy |
2 |
|
liver |
2 |
|
liver cirrhosis - blood - etiology |
2 |
|
lymphocytes - immunology |
2 |
|
macrophages - cytology |
2 |
|
membrane protein |
2 |
|
membrane proteins - biosynthesis - chemistry - physiology |
2 |
|
mesenteric arteries - drug effects - metabolism - physiopathology |
2 |
|
metabolic complications |
2 |
|
metabolic diseasec |
2 |
|
metabolic steatohepatitis |
2 |
|
metabolomics |
2 |
|
mice, inbred balb c |
2 |
|
mice, transgenic |
2 |
|
microbiota |
2 |
|
micrornas |
2 |
|
microscopy, electron |
2 |
|
mitochondrial dysfunction |
2 |
|
mitochondrial proteins - deficiency - genetics - metabolism |
2 |
|
models, animal |
2 |
|
models, genetic |
2 |
|
molecular chaperones - metabolism - physiology |
2 |
|
molecular physiology |
2 |
|
multienzyme complexes - metabolism |
2 |
|
multivariate analysis |
2 |
|
muscle proteins - chemistry |
2 |
|
muscle proteins - genetics - isolation & purification - metabolism |
2 |
|
muscle proteins - metabolism |
2 |
|
muscle proteins - metabolism - physiology |
2 |
|
muscle, skeletal - drug effects - metabolism |
2 |
|
muscle, smooth, vascular - metabolism |
2 |
|
myoblasts, skeletal - drug effects - metabolism |
2 |
|
myocardium - metabolism |
2 |
|
myocytes, cardiac - cytology - metabolism |
2 |
|
myocytes, cardiac - metabolism |
2 |
|
myography |
2 |
|
neonatal heart regeneration |
2 |
|
neurogenesis |
2 |
|
neutrophil |
2 |
|
nitric oxide synthase - antagonists & inhibitors - metabolism |
2 |
|
no |
2 |
|
non-invasive diagnosis |
2 |
|
nonesterified |
2 |
|
notch1 signaling |
2 |
|
nox1-nox4 |
2 |
|
obesity - etiology - metabolism - physiopathology |
2 |
|
obesity - metabolism |
2 |
|
obesity - metabolism - pathology |
2 |
|
olfactory bulb |
2 |
|
olfactory functions |
2 |
|
oncogene proteins - metabolism - pharmacology |
2 |
|
organ culture techniques |
2 |
|
oxidative metabolism |
2 |
|
p20 |
2 |
|
p53 |
2 |
|
palmitates - metabolism |
2 |
|
pamam |
2 |
|
pancreas |
2 |
|
pancreas - cytology |
2 |
|
peptide mapping |
2 |
|
peptides - pharmacology |
2 |
|
personalized risk stratification |
2 |
|
pet32 |
2 |
|
pharmacological intervention |
2 |
|
phosphatidylinositol 3-kinases - metabolism |
2 |
|
phospholipase |
2 |
|
phospholipase c beta |
2 |
|
phosphopeptides - chemistry |
2 |
|
phosphopeptides - isolation & purification |
2 |
|
phosphoprotein |
2 |
|
phosphoproteins - chemistry |
2 |
|
phosphoproteins - genetics - isolation & purification - metabolism |
2 |
|
photodynamic therapy |
2 |
|
physiology medical sciences |
2 |
|
pichia - genetics - metabolism |
2 |
|
piggybac |
2 |
|
polyethylene glycols - metabolism |
2 |
|
pparα |
2 |
|
precipitin tests |
2 |
|
precision medicine |
2 |
|
pregnancy |
2 |
|
progesterone - blood |
2 |
|
proinsulin processing |
2 |
|
protein folding |
2 |
|
protein isoforms - metabolism |
2 |
|
protein kinase c - antagonists & inhibitors - metabolism |
2 |
|
protein kinase c-alpha |
2 |
|
protein therapeutics |
2 |
|
protein-serine-threonine kinases - metabolism |
2 |
|
proteins - genetics - physiology - therapeutic use |
2 |
|
rac1 |
2 |
|
rap1 |
2 |
|
rats, wistar |
2 |
|
reactive oxidative species |
2 |
|
real-time polymerase chain reaction |
2 |
|
recombinant proteins - biosynthesis - chemistry - immunology - isolation & purification |
2 |
|
recombinant proteins - chemistry - pharmacology |
2 |
|
recombinant proteins - therapeutic use |
2 |
|
reference values |
2 |
|
regional blood flow |
2 |
|
reperfusion injury |
2 |
|
resting tension |
2 |
|
ritonavir - adverse effects - pharmacology |
2 |
|
rorγt |
2 |
|
rxr |
2 |
|
seipin |
2 |
|
serine - metabolism |
2 |
|
single nucleotide polmorphism |
2 |
|
sirtuin |
2 |
|
snare proteins - metabolism |
2 |
|
stem cells - cytology |
2 |
|
stomach |
2 |
|
stomach - cytology |
2 |
|
stroke risk |
2 |
|
subventricular zone |
2 |
|
tetrazolium salts - metabolism |
2 |
|
th17 |
2 |
|
th17 cell |
2 |
|
th2 immunity |
2 |
|
therapeutic target |
2 |
|
thiazoles - metabolism |
2 |
|
thioredoxin |
2 |
|
tissue distribution |
2 |
|
titin |
2 |
|
toll-like receptor-5 |
2 |
|
transcription, genetic |
2 |
|
transfection |
2 |
|
triglycerides - biosynthesis - blood |
2 |
|
two-hybrid system techniques |
2 |
|
type c phospholipases - genetics - metabolism |
2 |
|
type i diabetes |
2 |
|
uncoupling protein |
2 |
|
vasodilation - drug effects |
2 |
|
vasodilator agents - pharmacology |
2 |
|
venoms - pharmacology |
2 |
|
voluntary exercise |
2 |
|
xenopus |
2 |
|
xenopus laevis |
2 |
|
xenopus proteins - physiology |
2 |
|
yeast 2-hybrid system |
2 |
|
3t3-l1 adipogenesis |
1 |
|
3t3-l1 cell |
1 |
|
a-769662 |
1 |
|
acetyl-coa carboxylase |
1 |
|
acetyl-coa carboxylase - antagonists & inhibitors |
1 |
|
actin cytoskeleton |
1 |
|
actins - metabolism |
1 |
|
adaptor proteins, signal transducing - chemistry - isolation & purification |
1 |
|
adenosine kinase (adk) |
1 |
|
adenylate kinase - metabolism |
1 |
|
adhesion |
1 |
|
adipocyte-fatty acid binding protein |
1 |
|
adipocytes |
1 |
|
adipocytes - cytology - drug effects - enzymology - metabolism |
1 |
|
adipocytes - cytology - physiology |
1 |
|
adipocytokine |
1 |
|
adipogenesis - drug effects |
1 |
|
adipogenesis - drug effects - genetics |
1 |
|
adiponectin - biosynthesis - genetics |
1 |
|
adiponectin - blood - chemistry - genetics - metabolism - secretion |
1 |
|
adiponectin - blood - genetics - pharmacology |
1 |
|
adiponectin - deficiency - genetics - pharmacology |
1 |
|
adiponectin - genetics - metabolism - physiology |
1 |
|
adiponectin receptor 1 |
1 |
|
adiponectin receptor 2 |
1 |
|
adipor |
1 |
|
adipose biology |
1 |
|
adipose tissue browning |
1 |
|
adipose tissue macrophage |
1 |
|
adiposity |
1 |
|
adult-onset diabetes |
1 |
|
ahi1 |
1 |
|
airway responsiveness |
1 |
|
allergens - pharmacology |
1 |
|
ammonium sulfate - chemistry |
1 |
|
amp-activated protein kinase |
1 |
|
analysis of variance |
1 |
|
androstadienes - pharmacology |
1 |
|
angiotensin ii - administration and dosage - metabolism |
1 |
|
angiotensin ii - biosynthesis |
1 |
|
animal model |
1 |
|
anthropometry |
1 |
|
antigens, cd36 - metabolism |
1 |
|
antineoplastic agents, phytogenic - pharmacology |
1 |
|
antiviral agents |
1 |
|
atherosclerosis - enzymology |
1 |
|
australia |
1 |
|
azo compounds |
1 |
|
bezafibrate - pharmacology |
1 |
|
binding sites |
1 |
|
biological transport |
1 |
|
biological transport - drug effects |
1 |
|
bioreactors |
1 |
|
bmi |
1 |
|
body weight |
1 |
|
brefeldin a-inhibited guanine nucleotide exchange protein 3 |
1 |
|
bronchial hyperreactivity - immunology - prevention & control |
1 |
|
bronchoalveolar lavage fluid - cytology - immunology |
1 |
|
butyrates - pharmacology |
1 |
|
ca2+ |
1 |
|
cadherins - genetics - metabolism |
1 |
|
calcimycin - pharmacology |
1 |
|
calcium - physiology |
1 |
|
calcium-binding proteins - biosynthesis - genetics |
1 |
|
cardiac fibroblast |
1 |
|
cardiomyocyte |
1 |
|
cardiovascular complications |
1 |
|
cardiovascular disease risk |
1 |
|
cardiovascular disorders |
1 |
|
cardiovascular outcome |
1 |
|
carnitine o-palmitoyltransferase - deficiency - genetics |
1 |
|
carrier proteins - biosynthesis - genetics - metabolism |
1 |
|
carrier proteins - genetics - metabolism |
1 |
|
ccaat-enhancer-binding proteins - metabolism |
1 |
|
ccaat/enhancer-binding protein |
1 |
|
cell apoptosis |
1 |
|
cell differentiation - drug effects |
1 |
|
cell membrane - metabolism - physiology |
1 |
|
cell movement |
1 |
|
cell survival - drug effects |
1 |
|
cell viability |
1 |
|
cervical cancer |
1 |
|
chemokine cxcl2 |
1 |
|
chemokines - metabolism |
1 |
|
chiroptera - genetics - physiology |
1 |
|
cho cells |
1 |
|
chromatography, gel |
1 |
|
chromatography, ion exchange |
1 |
|
chronic hepatitis c |
1 |
|
circulating factors |
1 |
|
clone cells - drug effects |
1 |
|
coatomer protein - metabolism |
1 |
|
coculture techniques |
1 |
|
colitis - chemically induced - metabolism - pathology - prevention & control |
1 |
|
collagen |
1 |
|
colon - drug effects - metabolism - pathology |
1 |
|
colorectal neoplasms - pathology - therapy |
1 |
|
coloring agents |
1 |
|
compound a |
1 |
|
computational biology |
1 |
|
coupling factor 6 |
1 |
|
cp: metabolism |
1 |
|
cpt1 activity |
1 |
|
cpt1 expression |
1 |
|
cpt1c knockout |
1 |
|
cricetinae |
1 |
|
cricetulus |
1 |
|
crystallization |
1 |
|
crystallography, x-ray |
1 |
|
csf |
1 |
|
cyclic amp-dependent protein kinases - antagonists & inhibitors |
1 |
|
cytokines - blood |
1 |
|
cytokines - metabolism |
1 |
|
cytoplasm - metabolism |
1 |
|
cytoskeleton - metabolism |
1 |
|
cytosol - drug effects - metabolism |
1 |
|
cytosol - metabolism |
1 |
|
dag repartitioning |
1 |
|
dextran sulfate |
1 |
|
diabetes mellitus, experimental - blood - drug therapy - genetics - metabolism |
1 |
|
diabetes mellitus, experimental - pathology - physiopathology |
1 |
|
diabetes mellitus, type 2 |
1 |
|
diabetes mellitus, type 2 - blood - pathology - physiopathology |
1 |
|
diabetes mellitus, type 2 - blood - physiopathology |
1 |
|
diet induced obesity |
1 |
|
diet-induced hepatic steatosis |
1 |
|
dietary fats - adverse effects |
1 |
|
dithiothreitol - pharmacology |
1 |
|
dna, complementary - biosynthesis - isolation & purification |
1 |
|
dna, complementary - chemistry - genetics - isolation & purification |
1 |
|
dna-directed rna polymerases |
1 |
|
dvt |
1 |
|
dyrk1a |
1 |
|
echocardiography |
1 |
|
endoplasmic reticulum - metabolism |
1 |
|
endoplasmic reticulum - metabolism - virology |
1 |
|
endoplasmic reticulum stress |
1 |
|
endothelial cell |
1 |
|
endothelial cells - metabolism |
1 |
|
endothelium, vascular - physiology |
1 |
|
endothelium, vascular - physiopathology |
1 |
|
endothelium-dependent relaxing factors - blood |
1 |
|
energy homeostasis |
1 |
|
england |
1 |
|
eosinophil |
1 |
|
epidermal growth factor - metabolism |
1 |
|
epididymis |
1 |
|
equilibrative nucleoside transporter (ent) |
1 |
|
exocytosis |
1 |
|
extracellular adenosine |
1 |
|
extracellular amp |
1 |
|
extracellular matrix |
1 |
|
fa oxidation |
1 |
|
fa synthesis |
1 |
|
fabp2 |
1 |
|
fatty acid oxidation |
1 |
|
fatty acids |
1 |
|
fatty liver - blood |
1 |
|
femoral artery - pathology |
1 |
|
fenofibrate |
1 |
|
fenofibrate intervention and event lowering in diabetes (field) study |
1 |
|
fermentation |
1 |
|
fetal–maternal health |
1 |
|
fibroblast growth factor 2 - metabolism |
1 |
|
fibroblast growth factor 21 (fgf21) |
1 |
|
fibroblast growth factors - blood - genetics - physiology |
1 |
|
fibroblast growth factors - genetics - metabolism |
1 |
|
fibroblast transformation |
1 |
|
fluorescent antibody technique |
1 |
|
fluorobenzenes - pharmacology |
1 |
|
fluorouracil - pharmacology |
1 |
|
forkhead transcription factors - genetics |
1 |
|
foxo1a |
1 |
|
fto |
1 |
|
fusion |
1 |
|
galectin-3 |
1 |
|
gamma-glutamyltransferase - blood |
1 |
|
gastric bypass |
1 |
|
gene expression profiling |
1 |
|
gene expression regulation - drug effects |
1 |
|
gene expression regulation - drug effects - physiology |
1 |
|
genome-wide association study |
1 |
|
glucagon - blood |
1 |
|
gluconeogenesis - physiology |
1 |
|
glucose clamp technique |
1 |
|
glucose intolerance |
1 |
|
glucose intolerance - blood |
1 |
|
glucose intolerance - enzymology - etiology - metabolism |
1 |
|
glucose metabolism |
1 |
|
glutathione transferase - metabolism |
1 |
|
glycogen - metabolism |
1 |
|
glycoprotein-membrane trafficking |
1 |
|
glycoproteins - genetics |
1 |
|
glycoproteins - metabolism |
1 |
|
glycoside hydrolases - pharmacology |
1 |
|
golgi apparatus - metabolism |
1 |
|
gpr110 |
1 |
|
gtpase-activating proteins - chemistry - metabolism - physiology |
1 |
|
gut microbiome |
1 |
|
hdl |
1 |
|
health behaviour change |
1 |
|
health promotion |
1 |
|
heart failure - blood |
1 |
|
hepacivirus - genetics |
1 |
|
hepatic stellate cell |
1 |
|
hepatitis c, chronic - blood - diagnosis - physiopathology |
1 |
|
hepatocellular injury |
1 |
|
hepatokine |
1 |
|
hibernate |
1 |
|
hibernation |
1 |
|
histone deacetylases - metabolism |
1 |
|
his×6-tag |
1 |
|
hnf-4α |
1 |
|
homocysteine |
1 |
|
hsp70 heat-shock proteins - biosynthesis - genetics - metabolism |
1 |
|
human |
1 |
|
human interleukin-7 |
1 |
|
hyperandrogenism |
1 |
|
hyperinsulinemic-euglycemic clamp |
1 |
|
hypertension (high blood pressure) |
1 |
|
ibat |
1 |
|
ige |
1 |
|
immune cells |
1 |
|
immune regulation |
1 |
|
immunity |
1 |
|
immunoglobulin e - blood |
1 |
|
immunometabolism |
1 |
|
inducible nitric oxide synthase |
1 |
|
inflammation - enzymology |
1 |
|
insulin signaling |
1 |
|
insulin-like growth factor i - metabolism - pharmacology |
1 |
|
insulin-sensitising effects |
1 |
|
intercellular signaling peptides and proteins - metabolism |
1 |
|
interleukin-1beta - metabolism |
1 |
|
interleukin-3 |
1 |
|
interleukin-3 - genetics - immunology - isolation & purification - secretion |
1 |
|
interleukin-6 - metabolism |
1 |
|
interleukin-7 - biosynthesis - genetics - isolation & purification - pharmacology |
1 |
|
interleukin-8 |
1 |
|
interleukin-8 - chemistry - genetics - metabolism |
1 |
|
intestinal mucosa - metabolism |
1 |
|
intra-abdominal fat - metabolism - physiopathology |
1 |
|
intramyocellular lipid |
1 |
|
islet |
1 |
|
isoenzymes - genetics - metabolism |
1 |
|
laminin - antagonists & inhibitors - genetics |
1 |
|
latent autoimmune diabetes in adults |
1 |
|
lcn2 protein, human |
1 |
|
ldl |
1 |
|
lentivirus |
1 |
|
lentivirus - genetics |
1 |
|
leptin - metabolism |
1 |
|
leptin - pharmacology |
1 |
|
leukocytes - drug effects |
1 |
|
lifestyle intervention |
1 |
|
lifestyle modification |
1 |
|
light |
1 |
|
lipid metabolism - physiology |
1 |
|
lipidomics |
1 |
|
lipids - blood |
1 |
|
liver - metabolism - physiopathology - virology |
1 |
|
liver cirrhosis - metabolism - pathology |
1 |
|
liver diseases - blood - metabolism |
1 |
|
liver insulin sensitivity |
1 |
|
liver steatosis |
1 |
|
lrp6 |
1 |
|
lung |
1 |
|
lung - drug effects - physiology |
1 |
|
lymph node metastasis |
1 |
|
m6a |
1 |
|
macaca mulatta |
1 |
|
mannose-binding lectins |
1 |
|
map kinase signaling system |
1 |
|
marine collagen peptide |
1 |
|
matrix metalloproteinase |
1 |
|
maturity-onset diabetes of the young |
1 |
|
medicine |
1 |
|
membrane glycoproteins |
1 |
|
membrane proteins - biosynthesis - genetics - metabolism |
1 |
|
membrane proteins - metabolism |
1 |
|
men |
1 |
|
meta-analysis |
1 |
|
metabolic disorder |
1 |
|
metabolic homeostasis |
1 |
|
metabolic hormones |
1 |
|
metabolites |
1 |
|
microbiome dynamics |
1 |
|
microparticles |
1 |
|
microrna |
1 |
|
microscopy, confocal |
1 |
|
microtubules |
1 |
|
microtubules - metabolism |
1 |
|
migration |
1 |
|
mitogen-activated protein kinase 1 - metabolism |
1 |
|
mitogen-activated protein kinase 3 |
1 |
|
mitogen-activated protein kinases - metabolism |
1 |
|
mitogens - metabolism - pharmacology |
1 |
|
mitosis - drug effects |
1 |
|
mitotic clonal expansion |
1 |
|
mody |
1 |
|
molecular chaperones - biosynthesis - genetics - metabolism |
1 |
|
monocyte chemoattractant protein-1 |
1 |
|
monocytes - metabolism |
1 |
|
monogenic diabetes |
1 |
|
mortality |
1 |
|
mouse |
1 |
|
moyamoya disease |
1 |
|
mri |
1 |
|
mtorc1 |
1 |
|
muscle fibers, skeletal - drug effects - metabolism - physiology |
1 |
|
muscle fibers, skeletal - metabolism |
1 |
|
muscle lipids |
1 |
|
muscle satellite cells (muscs) |
1 |
|
muscle stimulation |
1 |
|
muscle sympathetic nervous activity |
1 |
|
muscle, skeletal - drug effects - metabolism - physiology |
1 |
|
muscle, skeletal - metabolism - physiology |
1 |
|
muscle, skeletal - metabolism - physiopathology - virology |
1 |
|
myocardium - enzymology - metabolism |
1 |
|
myokine |
1 |
|
n-linked glycosylation |
1 |
|
n-terminal pro-brain natriuretic peptide |
1 |
|
nafld |
1 |
|
napping duration |
1 |
|
neoplasm proteins - biosynthesis - genetics |
1 |
|
nerve tissue proteins - deficiency - genetics - metabolism |
1 |
|
nerve tissue proteins - genetics - metabolism |
1 |
|
net inhibitors |
1 |
|
neutrophil degranulation |
1 |
|
neutrophils |
1 |
|
nocodazole - pharmacology |
1 |
|
non-alcoholic fatty liver disease (nafld) |
1 |
|
non-esterified fatty acid |
1 |
|
nonalcoholic fatty liver diseases (nafld) |
1 |
|
northern blot |
1 |
|
obesity - blood - drug therapy - genetics - metabolism |
1 |
|
obesity - enzymology - etiology - metabolism |
1 |
|
offspring |
1 |
|
osteocalcin |
1 |
|
ovalbumin - pharmacology |
1 |
|
oxidative genes expression |
1 |
|
oxidative stress - drug effects |
1 |
|
paclitaxel - pharmacology |
1 |
|
pancreatic cancer |
1 |
|
pcsk1 |
1 |
|
pdk4 |
1 |
|
peptides - chemistry |
1 |
|
pgc-1α |
1 |
|
pgc1a |
1 |
|
phenotype |
1 |
|
phosphatidylinositol 3-kinase - metabolism |
1 |
|
phospholipase c gamma |
1 |
|
phospholipase c gamma - antagonists & inhibitors - genetics - physiology |
1 |
|
phosphorylation - drug effects - physiology |
1 |
|
pichia - metabolism |
1 |
|
pilot projects |
1 |
|
plasma lipidomic profile |
1 |
|
plasmids - genetics - metabolism |
1 |
|
plasmids - metabolism |
1 |
|
pneumonia - immunology - prevention & control |
1 |
|
population health |
1 |
|
ppar alpha - physiology |
1 |
|
pparδ |
1 |
|
pregnancy complication |
1 |
|
pregnancy complications |
1 |
|
pregnancy outcomes |
1 |
|
preventive cardiology |
1 |
|
prmt1 |
1 |
|
protein biosynthesis |
1 |
|
protein kinase c |
1 |
|
protein kinase cδ |
1 |
|
protein kinase inhibitors - pharmacology |
1 |
|
protein kinases - genetics |
1 |
|
protein multimerization |
1 |
|
protein renaturation |
1 |
|
protein sorting signals |
1 |
|
protein transport |
1 |
|
protein transport - drug effects |
1 |
|
protein-serine-threonine kinases - genetics |
1 |
|
protein-tyrosine kinases - genetics |
1 |
|
proteins - chemistry - metabolism |
1 |
|
purification |
1 |
|
pyrazoles - pharmacology |
1 |
|
pyrimidines - pharmacology |
1 |
|
pyrones - pharmacology |
1 |
|
rab gtp-binding proteins - metabolism |
1 |
|
rabbit |
1 |
|
receptor, angiotensin, type 1 - genetics - metabolism |
1 |
|
receptor, angiotensin, type 1 - metabolism |
1 |
|
receptor, angiotensin, type 2 - metabolism |
1 |
|
receptors, cell surface - genetics - metabolism |
1 |
|
receptors, tumor necrosis factor, type ii - blood |
1 |
|
recombinant fusion proteins - genetics - immunology - isolation & purification |
1 |
|
recombinant proteins - biosynthesis - genetics - isolation & purification - pharmacology |
1 |
|
recombinant proteins - chemistry - genetics - metabolism |
1 |
|
recombinant proteins - pharmacology |
1 |
|
renin-angiotensin system |
1 |
|
resistance |
1 |
|
resveratrol |
1 |
|
rhinolophus ferrumequinum |
1 |
|
rna - biosynthesis - isolation & purification |
1 |
|
rna, messenger - analysis |
1 |
|
rna, messenger - biosynthesis |
1 |
|
rna, messenger - genetics |
1 |
|
rna, messenger - genetics - metabolism |
1 |
|
rna, small interfering - genetics |
1 |
|
rna, small interfering - therapeutic use |
1 |
|
rna, viral - blood |
1 |
|
rotavirus |
1 |
|
rotavirus - genetics - growth & development - pathogenicity |
1 |
|
rotavirus - metabolism |
1 |
|
rotavirus infections - genetics - metabolism - virology |
1 |
|
scattering, radiation |
1 |
|
scd1 |
1 |
|
sepharose |
1 |
|
sequence alignment |
1 |
|
sequence analysis, dna |
1 |
|
serine - genetics - metabolism |
1 |
|
serum |
1 |
|
sex dimorphism |
1 |
|
sh3 domains |
1 |
|
sialic acids - metabolism |
1 |
|
sialyltransferases - metabolism |
1 |
|
single nucleotide polymorphisms |
1 |
|
sirna |
1 |
|
sleep disturbance |
1 |
|
sleep duration |
1 |
|
solubility |
1 |
|
sp sepharose |
1 |
|
spectrometry, mass, matrix-assisted laser desorption-ionization |
1 |
|
spodoptera - cytology |
1 |
|
src homology domains |
1 |
|
statin |
1 |
|
stress granules |
1 |
|
stress, physiological - metabolism |
1 |
|
subcutaneous fat - metabolism - physiopathology |
1 |
|
t-cadherin |
1 |
|
tctp |
1 |
|
tetrazolium salts |
1 |
|
the amp-activated protein kinase |
1 |
|
thiazoles |
1 |
|
thiophenes - pharmacology |
1 |
|
tmem18 |
1 |
|
toll-like receptor 4 - metabolism |
1 |
|
toxins, biological |
1 |
|
transcription |
1 |
|
transcription factor rela - metabolism |
1 |
|
transcription factors - metabolism |
1 |
|
transcriptomic analysis |
1 |
|
transformation, genetic |
1 |
|
transport vesicles - metabolism - physiology |
1 |
|
triacylglycerides |
1 |
|
triglyceride |
1 |
|
trinitrobenzenesulfonic acid |
1 |
|
troponin |
1 |
|
trypsin - metabolism - pharmacology |
1 |
|
tubulin - metabolism |
1 |
|
tumor markers, biological |
1 |
|
tumor necrosis factor-alpha - metabolism |
1 |
|
tunica media |
1 |
|
tunicamycin - pharmacology |
1 |
|
type-2 diabetes mellitus |
1 |
|
up-regulation |
1 |
|
vasodilation - physiology |
1 |
|
viral envelope proteins - metabolism |
1 |
|
viral load |
1 |
|
viral nonstructural proteins - biosynthesis - genetics - physiology |
1 |
|
viral nonstructural proteins - genetics |
1 |
|
viral nonstructural proteins - metabolism |
1 |
|
virus-host interactions |
1 |
|
whitening |
1 |
|
women reproduction |
1 |
|
ythdf3 |
1 |
|
“hub” genes |
1 |
